EP 1226435 A4 20041222 - AXOR35, A G-PROTEIN COUPLED RECEPTOR
Title (en)
AXOR35, A G-PROTEIN COUPLED RECEPTOR
Title (de)
AXOR35, EIN AN EIN G-PROTEIN GEKOPPELTER REZEPTOR
Title (fr)
AXOR35, RECEPTEUR COUPLE A LA PROTEINE G
Publication
Application
Priority
- US 0029461 W 20001026
- US 43189899 A 19991102
- US 49779000 A 20000203
Abstract (en)
[origin: WO0133221A1] AXOR35 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing AXOR35 polypeptides and polynucleotides in diagnostic assays.
IPC 1-7
G01N 33/53; G01N 33/567; C12P 21/06; C12P 21/04; C12N 1/20; C12N 15/00; C12N 15/09; C12N 15/63; C12N 15/70; C12N 15/74; C12N 5/00; C07K 14/705
IPC 8 full level
G01N 33/50 (2006.01); A61K 31/7088 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 1/00 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 13/00 (2006.01); A61P 13/12 (2006.01); A61P 19/02 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 29/02 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 37/02 (2006.01); A61P 37/08 (2006.01); C07D 233/54 (2006.01); C07D 403/12 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12P 21/02 (2006.01); C12P 21/04 (2006.01); G01N 33/15 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 3/10 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 13/00 (2017.12); A61P 13/12 (2017.12); A61P 19/02 (2017.12); A61P 25/00 (2017.12); A61P 25/16 (2017.12); A61P 25/18 (2017.12); A61P 25/22 (2017.12); A61P 25/24 (2017.12); A61P 25/28 (2017.12); A61P 29/00 (2017.12); A61P 29/02 (2017.12); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 37/02 (2017.12); A61P 37/08 (2017.12); C07D 233/64 (2013.01); C07D 403/12 (2013.01); C07K 14/705 (2013.01); A61K 38/00 (2013.01); C07B 2200/11 (2013.01)
Citation (search report)
- [E] WO 0125432 A2 20010412 - SCHERING CORP [US]
- [E] EP 1096009 A1 20010502 - PFIZER LTD [GB], et al
- [A] LEURS R ET AL: "Therapeutic potential of histamine H3 receptor agonists and antagonists", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 19, no. 5, 1 May 1998 (1998-05-01), pages 177 - 184, XP004121095, ISSN: 0165-6147
- [A] HILL S J ET AL: "INTERNATIONAL UNION OF PHARMACOLOGY. XIII. CLASSIFICATION OF HISTAMINE RECEPTORS", PHARMACOLOGICAL REVIEWS, WILLIAMS AND WILKINS INC., BALTIMORE, MD,, US, vol. 49, no. 3, September 1997 (1997-09-01), pages 253 - 278, XP000881903, ISSN: 0031-6997
- See references of WO 0133221A1
Designated contracting state (EPC)
AT GB
DOCDB simple family (publication)
WO 0133221 A1 20010510; EP 1226435 A1 20020731; EP 1226435 A4 20041222; JP 2003512854 A 20030408
DOCDB simple family (application)
US 0029461 W 20001026; EP 00973867 A 20001026; JP 2001535055 A 20001026